Dutch Diabetes Care Devices Market: By Device, Insulin Delivery Devices ), By End-user, and Country

Dutch Diabetes Care Devices Market Size, Share, Growth, Trends, and Global Industry Analysis: By Device ((Blood Glucose Monitoring Systems (Self-monitoring Blood Glucose Monitoring Systems, Continuous Glucose Monitoring systems, Test strips/Test Papers and Lancets/Lancing Devices), Insulin Delivery Devices (Insulin Pumps, Insulin Pens, Insulin Syringes and Needles and Others)), By End-user (Hospitals, Specialty Clinics and Home Care), and Country

Dutch Diabetes Care Devices Market was valued at US$ 47,298.2 million in 2023 and grew at 10.3% CAGR during the forecast years (2024-2030). The medical devices for the care of diabetes are aimed at assisting people who are suffering from the disease. Equipment ranges from blood glucose monitoring devices to insulin delivery devices and other products that make the management of diabetes easy. Generally, such devices aim to assist patients in maintaining appropriate glucose levels, avoiding complications, and enhancing the quality of life.

The Dutch Diabetes Care Devices Market is well-established and growing in the Netherlands healthcare industry. Such a market would comprise a range of products, including glucose meters, insulin pumps, continuous glucose monitoring systems, insulin pens, and their accessories. In addition, infrastructural strength of the healthcare system with a growing pool of diabetic patients and the emergence of new technologies in medical treatment would favor the market. The number of diabetes cases in the Netherlands is rising, driving the demand for diabetes care devices. This increase is largely due to aging populations, sedentary lifestyles, and dietary habits. For instance, in the Netherlands, the current approximated national prevalence of diabetes mellitus at all ages is 6.9%, with an estimated number of 1.2 million patients, a number expected to rise to 1.4 million by 2040.  

Additionally, continuous innovations in diabetes management technologies, such as advanced CGM systems and smart insulin pens, are pushing market growth. Whereas, the cost of acquiring and maintaining advanced devices like insulin pumps and CGMs can be a barrier, particularly for uninsured individuals. However, the integration of diabetes care devices with digital health platforms offers opportunities for more personalized and efficient diabetes management.

Dutch Diabetes Care Devices Market Key Developments:

  • In 2023 - Roche Introduces the Accu-Chek® Guide System. Roche, one of the diabetes care leaders, has launched the Accu-Chek® Guide system in the Dutch market. Using this system, diabetic patients will be able to measure blood glucose more conveniently than with previously available devices.
  • 2022-Abbott FreeStyle Libre 3 Approved. Abbott received an approval for FreeStyle Libre 3, its CGM system, in the Netherlands. That is a system performing real-time glucose readings and highly valued because of its tiny size and high accuracy.
  • 2021 - MiniMed™ 780G System. Medtronic, the global leader in diabetes care technologies, announces the Netherlands introduction of the MiniMed™ 780G System.

Dutch Diabetes Care Devices Market Dynamics

One of the major driving factors for the Dutch Diabetes Care Devices Market is the growing prevalence of diabetes. This increase in diabetes cases has led to a higher demand for effective diabetes management solutions, including advanced care devices. According to National Library Of Medicine, in 2018, 6.5% of the Dutch population aged 18 and above were identified as having type 2 diabetes. The type 2 diabetes population increased by 2.3% compared with 2016. In 2018, the mean age of the Dutch type 2 diabetes population was 68.7 years and 46.7% of the population was woman. The Netherlands has seen a significant rise in diabetes cases over the years. This trend is primarily due to lifestyle changes, including increased consumption of unhealthy foods and a rise in obesity rates.

Dutch Diabetes Care Devices Market Segmentation Analysis

Report Benchmarks

Details

Market Size in 2023

US$ 47,298.2 million

By Device

  • Blood Glucose Monitoring Systems
    • Self-monitoring Blood Glucose Monitoring Systems
    • Continuous Blood Glucose Monitoring systems
    • Test strips/Test Papers
    • Lancets/Lancing Devices
  • Insulin Delivery Devices
    • Insulin Pumps
    • Insulin Pens
    • Insulin Syringes and Needles
    • Others

By End User

  • Hospitals
  • Specialty Clinics
  • Home Care

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies.
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenarios.

Download Free Sample Report

Frequently Asked Questions

Diabetes care devices are medical tools used to monitor and manage blood glucose levels in individuals with diabetes, including glucose meters, insulin pumps, and continuous glucose monitoring systems.

The market is primarily driven by the increasing prevalence of diabetes in the Netherlands, supported by government policies and technological advancements in diabetes management devices.

High costs of advanced devices and the complexity of using them are significant challenges in the market.

Yes, recent developments include the launch of the MiniMed™ 780G system by Medtronic in 2021, the approval of Abbott’s FreeStyle Libre 3 in 2022, and the introduction of Roche’s Accu-Chek® Guide system in 2023.

The Netherlands leads due to its strong healthcare system, high awareness and adoption rates of advanced devices, and substantial government support.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Dutch Diabetes Care Devices Market Introduction
2.1. Dutch Diabetes Care Devices Market - Taxonomy
2.2. Dutch Diabetes Care Devices Market - Definitions
2.2.1. Device
2.2.2. End-user
2.2.3. Country
3. Dutch Diabetes Care Devices Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Key Developments
4. Dutch Diabetes Care Devices Market By Device, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
4.1. Blood Glucose Monitoring Systems
4.1.1. Self-monitoring Blood Glucose Monitoring Systems
4.1.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
4.1.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.1.1.3. Market Opportunity Analysis
4.1.2. Continuous Glucose Monitoring systems
4.1.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
4.1.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.1.2.3. Market Opportunity Analysis
4.1.3. Test strips/Test Papers
4.1.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
4.1.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.1.3.3. Market Opportunity Analysis
4.1.4. Lancets/Lancing Devices
4.1.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
4.1.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.1.4.3. Market Opportunity Analysis
4.2. Insulin Delivery Devices
4.2.1. Insulin Pumps
4.2.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
4.2.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.2.1.3. Market Opportunity Analysis
4.2.2. Insulin Pens
4.2.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
4.2.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.2.2.3. Market Opportunity Analysis
4.2.3. Insulin Syringes and Needles
4.2.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
4.2.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.2.3.3. Market Opportunity Analysis
4.2.4. Others
4.2.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
4.2.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.2.4.3. Market Opportunity Analysis
5. Dutch Diabetes Care Devices Market By End-user, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
5.1. Hospitals and Specialty Clinics
5.1.1 Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Home Care
5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
6. Dutch Diabetes Care Devices Market By Country, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
6.1. Netherland
6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Belgium
6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Aruba
6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Rest of Dutch
6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. Netherland Diabetes Care Devices Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
7.1. Device Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
7.1.1. Blood Glucose Monitoring Systems
7.1.1.1. Self-monitoring Blood Glucose Monitoring Systems
7.1.1.2. Continuous Glucose Monitoring systems
7.1.1.3. Test strips/Test Papers
7.1.1.4. Lancets/Lancing Devices
7.1.2. Insulin Delivery Devices
7.1.2.1. Insulin Pumps
7.1.2.2. Insulin Pens
7.1.2.3. Insulin Syringes and Needles
7.1.2.4. Others
7.2. End-user Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
7.2.1. Hospitals and Specialty Clinics
7.2.2. Home Care
8. Belgium Diabetes Care Devices Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
8.1. Device Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
8.1.1. Blood Glucose Monitoring Systems
8.1.1.1. Self-monitoring Blood Glucose Monitoring Systems
8.1.1.2. Continuous Glucose Monitoring systems
8.1.1.3. Test strips/Test Papers
8.1.1.4. Lancets/Lancing Devices
8.1.2. Insulin Delivery Devices
8.1.2.1. Insulin Pumps
8.1.2.2. Insulin Pens
8.1.2.3. Insulin Syringes and Needles
8.1.2.4. Others
8.2. End-user Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
8.2.1. Hospitals and Specialty Clinics
8.2.2. Home Care
9. Aruba Diabetes Care Devices Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
9.1. Device Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
9.1.1. Blood Glucose Monitoring Systems
9.1.1.1. Self-monitoring Blood Glucose Monitoring Systems
9.1.1.2. Continuous Glucose Monitoring systems
9.1.1.3. Test strips/Test Papers
9.1.1.4. Lancets/Lancing Devices
9.1.2. Insulin Delivery Devices
9.1.2.1. Insulin Pumps
9.1.2.2. Insulin Pens
9.1.2.3. Insulin Syringes and Needles
9.1.2.4. Others
9.2. End-user Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
9.2.1. Hospitals and Specialty Clinics
9.2.2. Home Care
10. Rest of Dutch Diabetes Care Devices Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
10.1. Device Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.1.1. Blood Glucose Monitoring Systems
10.1.1.1. Self-monitoring Blood Glucose Monitoring Systems
10.1.1.2. Continuous Glucose Monitoring systems
10.1.1.3. Test strips/Test Papers
10.1.1.4. Lancets/Lancing Devices
10.1.2. Insulin Delivery Devices
10.1.2.1. Insulin Pumps
10.1.2.2. Insulin Pens
10.1.2.3. Insulin Syringes and Needles
10.1.2.4. Others
10.2. End-user Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
7.2.1. Hospitals and Specialty Clinics
10.2.2. Home Care
11. Competition Landscape
11.1. Strategic Dashboard of Top Market Players
11.2. Company Profiles (Introduction, Financial Analysis, By Product Offerings, Key Developments, Strategies, and SWOT Analysis)
11.2.1. Dexcom Inc.
11.2.2. Insulet Corporation
11.2.3. Medtronic PLC
11.2.4. Roche Diabetes Care
11.2.5. Novo Nordisk A/S
11.2.6. Ascensia Diabetes Care
11.2.7. Lifescan
11.2.8. Abbott Diabetes Care
11.2.9. Lilly Netherlands
11.2.10. Sanofi
12. Research Methodology
13. Key Assumptions and Acronyms

Key Market Players

• Dexcom Inc.
• Insulet Corporation
• Medtronic PLC
• Roche Diabetes Care
• Novo Nordisk A/S
• Ascensia Diabetes Care
• Lifescan
• Abbott Diabetes Care
• Lilly Netherlands
• Sanofi

Related Industry Reports